ECSP982751A - USE OF SUBSTITUTED AMINOMETIL-CHROMANES FOR THE IMPEDIMENT OF NEURONAL DEGENERATION AND FOR THE STIMULUS OF NEURONAL REGENERATION - Google Patents

USE OF SUBSTITUTED AMINOMETIL-CHROMANES FOR THE IMPEDIMENT OF NEURONAL DEGENERATION AND FOR THE STIMULUS OF NEURONAL REGENERATION

Info

Publication number
ECSP982751A
ECSP982751A ECSP982751A ECSP982751A EC SP982751 A ECSP982751 A EC SP982751A EC SP982751 A ECSP982751 A EC SP982751A EC SP982751 A ECSP982751 A EC SP982751A
Authority
EC
Ecuador
Prior art keywords
neuronal
substituted
aminometil
chromanes
impediment
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Ervin Horvath
Reinhard Jork
Thomas Fahrig
Irene Gerlach
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP982751 priority Critical patent/ECSP982751A/en
Publication of ECSP982751A publication Critical patent/ECSP982751A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se refiere al uso de aminometil-cromanos sustituidos para el tratamiento de la degeneración neuronal y para el estimulo de la regeneración neuronal en lesiones cerebrales y enfermedades crónicas del sistema nervioso.The present invention relates to the use of substituted aminomethylchromans for the treatment of neuronal degeneration and for the stimulation of neuronal regeneration in brain injuries and chronic diseases of the nervous system.

ECSP982751 1998-11-24 1998-11-24 USE OF SUBSTITUTED AMINOMETIL-CHROMANES FOR THE IMPEDIMENT OF NEURONAL DEGENERATION AND FOR THE STIMULUS OF NEURONAL REGENERATION ECSP982751A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP982751 ECSP982751A (en) 1998-11-24 1998-11-24 USE OF SUBSTITUTED AMINOMETIL-CHROMANES FOR THE IMPEDIMENT OF NEURONAL DEGENERATION AND FOR THE STIMULUS OF NEURONAL REGENERATION

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP982751 ECSP982751A (en) 1998-11-24 1998-11-24 USE OF SUBSTITUTED AMINOMETIL-CHROMANES FOR THE IMPEDIMENT OF NEURONAL DEGENERATION AND FOR THE STIMULUS OF NEURONAL REGENERATION

Publications (1)

Publication Number Publication Date
ECSP982751A true ECSP982751A (en) 1999-04-16

Family

ID=42043670

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP982751 ECSP982751A (en) 1998-11-24 1998-11-24 USE OF SUBSTITUTED AMINOMETIL-CHROMANES FOR THE IMPEDIMENT OF NEURONAL DEGENERATION AND FOR THE STIMULUS OF NEURONAL REGENERATION

Country Status (1)

Country Link
EC (1) ECSP982751A (en)

Similar Documents

Publication Publication Date Title
SV1998000138A (en) USE OF SUBSTITUTED AMINOMETIL-CHROMANES FOR THE IMPEDIMENT OF NEURONAL DEGENERATION AND FOR THE STIMULUS OF NEURONAL REGENERATION REF.LEA 32408
CY1123734T1 (en) COMPLEMENT SUPPRESSION FOR ENHANCED NERVE REGENERATION
PT1248643E (en) USEFULNESS OF COPOLYMER 1 AND CONGENERAL AND T-CELLED PEOPLE AND POLYMPEPTIDES TREATED WITH THESE COMPOUNDS FOR NEUROPROTECTING THERAPY
ATE399553T1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING DEXTROMETHORPHAN AND QUINIDENE FOR THE TREATMENT OF NEUROLOGICAL DISEASES
ATE381935T1 (en) USE OF TRIACETYLURIDINE TO TREAT MITOCHONDRIAL DISEASES
DE69827513D1 (en) ARRANGEMENT FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS BY INFUSION OF NERVOUS GROWTH FACTORS IN THE BRAIN
NO20022585L (en) Pyrrolidine acetamide derivative alone or in combination for the treatment of central nervous system disorders
DE60037013D1 (en) NEUROTROPIC SUBSTITUTED PYRIMIDINES
CY1115617T1 (en) USE OF PATIENTS IN TREATMENT OF DISEASES THAT ARE CONCERNED WITH THE PROTEIN TOWARDS WHICH INCLUDE THE DISEASE
HN1998000027A (en) Arylsulphonamides and analogues
DK1303495T3 (en) Substituted 5-alkylnylpyrimidines with neurotrophic activity
DE602006020353D1 (en) Progesterone dosage instructions in the treatment of traumatic brain injury
ES2058592T3 (en) THE USE OF PHYSIOLOGICALLY ACTIVE SUBSTANCES FOR THE MANUFACTURE OF MEDICINES FOR BRAIN AND NEURONAL DISEASES.
AP2002002620A0 (en) Substituted arylpyrazines
WO1999060021A3 (en) Use of activated t cells, nervous system-specific antigens for treating disorders of the nevrous system
DE60333857D1 (en) Oxytocin for the treatment of autism and Asperger's syndrome
ES2086666T3 (en) BRAIN ACTIVATION COMPOSITIONS.
EP1043983A4 (en) TETRACYCLINE AND / OR TETRACYCLINE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF CEREBROVASCULAR DISEASES OF THE NERVOUS SYSTEM
DK0646009T3 (en) Use of guanosine for the manufacture of drugs intended to treat cerebral malfunctions
BR0011363A (en) Il6ril6 chimera for the treatment of neurodegenerative diseases
ECSP982751A (en) USE OF SUBSTITUTED AMINOMETIL-CHROMANES FOR THE IMPEDIMENT OF NEURONAL DEGENERATION AND FOR THE STIMULUS OF NEURONAL REGENERATION
ATE295162T1 (en) THERAPEUTIC USE OF CANNABINOIDS FOR BRAIN TUMOR TREATMENT
PT1135134E (en) USE OF NEUROTROPHIC FACTOR STIMULATORS FOR THE TREATMENT OF NEURODEGENERATIVE OPHTHALMIC DISEASES
WO2001082954A3 (en) Ceruloplasmin and uses thereof in neurodegenerative related conditions
BR0317772A (en) Method of treating a behavioral disorder, use of a compound, and therapeutic agent for a behavioral disorder